Detail of > 10418-03-8
- MSDS Download

- CAS Number:
- 10418-03-8
- Name:
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-
- Superlist Name:
- Stanozolol
- Formula:
- C21H32N2O
- Molecular Structure:
![Molecular Structure of 10418-03-8 (2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-)](http://www.lookchem.com/300w/2010/0612/10418-03-8.jpg)
- Synonyms:
- 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI);17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol;17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol;17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole;17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole;Anabol;Androstanazol;Androstanazolestanazol;Estazol;Stanazolol;Stromba;Strombaject;Tevabolin;Win 14833;Winstrol;
- Molecular Weight:
- 328.49
- EINECS:
- 233-894-8
- Density:
- 1.129 g/cm3
- Melting Point:
- 242 °C
- Boiling Point:
- 490.8 °C at 760 mmHg
- Flash Point:
- 250.7 °C
- Appearance:
- white to light yellow powder
- Hazard Symbols:
Xn,
Xi- Risk Codes:
- 63
- Safety:
- 53-22-36/37/39-36-26Details
- Deleted CAS:
- 17966-55-1|69353-49-7
Related products
- 10418-03-82'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-
- 22957-48-82'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (17b)- (9CI)
- 65-04-3Androst-1-en-3-one,17-hydroxy-17-methyl-, (5a,17b)-
- 65-06-5Androst-1-en-3-one,17-hydroxy-, (5a,17b)-
- 153-00-4Androst-1-en-3-one,17-hydroxy-1-methyl-, (5a,17b)-
- 6176-38-1Androst-1-en-3-one,17-hydroxy-2,17-dimethyl-, (5a,17b)-
- 521-11-9Androstan-3-one,17-hydroxy-17-methyl-, (5a,17b)-
- 521-18-6Androstan-3-one,17-hydroxy-, (5a,17b)-
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 27216-37-1a-D-Glucopyranoside,6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-b-D-fructofuranosyl, 6-acetate2,3,4-tris(2-methylpropanoate)
- 6259-66-11,3,6-Naphthalenetrisulfonicacid, 7-hydroxy-
- 452-75-5Benzene,4-chloro-2-fluoro-1-methyl-
- 10418-03-82'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-
- 134480-46-9Pyridine,4-[2-(heptylthio)ethyl]-
- 53716-50-0Oxfendazole
- 3691-35-81H-Indene-1,3(2H)-dione,2-[2-(4-chlorophenyl)-2-phenylacetyl]-
- 88255-01-0Ethanesulfonic acid,2-[[[(methoxycarbonyl)amino][[2-nitro-5-(propylthio)phenyl]amino]methylene]amino]-
- 29197-94-2Methanesulfonic acid,1-[(4-methyl-2-oxo-2H-1-benzopyran-7-yl)amino]-, sodium salt (1:1)
- 21440-97-12H-3,1-Benzoxazin-2-one,6-bromo-1,4-dihydro-4,4-dimethyl-
- 142-22-32,5,8,10-Tetraoxatridec-12-enoicacid, 9-oxo-, 2-propen-1-yl ester
- 13081-44-22-Propenamide,N-[2-(dimethylamino)ethyl]-2-methyl-
- 15402-84-3Benzeneethanamine,2-methoxy-a-methyl-
- 536-40-3Benzoic acid,4-chloro-, hydrazide
- 992-78-9Coenzyme Q10-hydroquinone
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(41)
India(2)
Macao(2)
United States(2)
Cameroon(1)
Italy(1)
China(Hongkong)(1)
- Business Type:
- Importer/Exporter(38)Manufacturers(3)Lab/Research institutions(2)
- Certificates:
- ISO(1)Production License(1)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol
- Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol. Kluft, C.; Bertina, R. M.; Preston, F. E.; Malia, R. G.; Blamey, S. L.Chemicals with cas numbers 9001-25-6 and 9001-28-9 also play role.; Lowe, G. D. O.; Forbes, C. D. (Gaubius Inst., TNO, Leiden 2313 AD, Neth.). Thromb. Res., 33(3), 297-304 (English) 1984. CODEN: THBRAA. ISSN: 0049-3848. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) After both oral and i.m. administration, the anabolic steroid stanozolol [10418-03-8] increased protein C antigen concns. in circulating blood. In healthy young volunteers who received stanozolol orally, 10 mg/day, the av. increase was 1.5-1.6 times the normal concns. after 3-6 wk' treatment and was accompanied by more moderate increases in the other vitamin K-dependent factors (blood coagulation factor II [9001-26-7], IX [9001-28-9], and X [9001-29-0] to 1.4, 1.4 and 1.2 times their normal concn., resp. However, there was no change in factor VII [9001-25-6]. In elderly surgical patients, i.m. injection (50 mg) one day prior to surgery induced a moderate increase within 24 h (to 1.11 times the pretreatment concn.) and also 7 days after operation (to 1.19 times), and reduced the postoperative fall in protein C. Stanozolol administration seems to be a promising pharmacol. method for increasing anticoagulation protein C levels in congenital and acquired deficiencies. .
- Experimental study on the hemopoietic effect of adrenergic and cholinergic drugs
- Experimental study on the hemopoietic effect of adrenergic and cholinergic drugs. Cao, Luxian; Cao, Chengping; Da, Wanming; Huang, Yongshi; Li, Pingsheng; Ye, Qingfang (Lanzhou Mil. Dist. Gen. Hosp., Lanzhou, Peop. Rep. China). Zhonghua Xueyexue Zazhi, 4(4), 232-3 (Chinese) 1983. CODEN: CHTCD7. ISSN: 0253-2727. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) The splenic colony-forming units (CFUs) and spleen wt. 525-66-6 and 55869-99-3 are also in the experiment. were both significantly increased in mice after oral administration of propranolol [525-66-6] (10 mg/kg) and stanozolol [10418-03-8] (30 mg/kg), but not in mice following i.p. injection of anisodamine [55869-99-3] (5mg/kg) and galanthamine [357-70-0] (2 mg/kg). In another expt., oral administration of salbutamol [18559-94-9] (8 mg/kg) significantly increased the splenic CFUs but not spleen wt. Thus, b-adrenergic, but not cholinergic, blockers may effectively stimulate hemopoietic activity. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

